Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 at the pre‐synaptic site: A 16‐years perspective
Francesca Pischedda, Giovanni Piccoli
Journal of Neurochemistry (2020) Vol. 157, Iss. 2, pp. 297-311
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Loss of LRRK2 activity induces cytoskeleton defects and oxidative stress during porcine oocyte maturation
Yuxia Wei, Ya-Han Wang, Xiaoting Yu, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors
Dan Dou, Jayne Aiken, Erika L.F. Holzbaur
The Journal of Cell Biology (2024) Vol. 223, Iss. 6
Open Access | Times Cited: 7
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2025)
Open Access
Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice
Daniela Mercatelli, Alberto Brugnoli, Anna Maio, et al.
Neurobiology of Disease (2025), pp. 106881-106881
Open Access
The Role of LRRK2 in Intracellular Organelle Dynamics
C. Alexander Boecker
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 167998-167998
Open Access | Times Cited: 10
LRRK2 regulates synaptic function through BDNF signaling and actin cytoskeleton
Giulia Tombesi, Shiva N. Kompella, Giulia Favetta, et al.
(2024)
Open Access | Times Cited: 3
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2024)
Open Access | Times Cited: 3
Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
Charlotte F. Brzozowski, Baraa Hijaz, Vijay P. Singh, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice
Mengfei Bu, Jordan Follett, Isaac Deng, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019Smodel of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
LRRK2 signaling in neurodegeneration: two decades of progress
Lucia Iannotta, Elisa Greggio
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 859-872
Closed Access | Times Cited: 18
LRRK2‐G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons
Olga Skiteva, Ning Yao, Giacomo Sitzia, et al.
Journal of Neurochemistry (2022) Vol. 161, Iss. 2, pp. 158-172
Open Access | Times Cited: 13
Multiple Pathways of LRRK2-G2019S/Rab10 Interaction in Dopaminergic Neurons
Alison Fellgett, C. A. Middleton, Jack Munns, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 4, pp. 1805-1820
Open Access | Times Cited: 15
Roles of neuronal lysosomes in the etiology of Parkinson's disease
Mattia Volta
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 1981-1983
Open Access | Times Cited: 6
Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models
Mattia Volta
Neurotherapeutics (2022) Vol. 20, Iss. 1, pp. 127-139
Open Access | Times Cited: 9
Aberrant Patterns of Sensory-Evoked Activity in the Olfactory Bulb of LRRK2 Knockout Mice
Andrea Maset, Marica Albanesi, Antonio di Soccio, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3212-3212
Open Access | Times Cited: 5
LRRK2 regulates synaptic function through BDNF signaling and actin cytoskeleton
Giulia Tombesi, Shiva N. Kompella, Giulia Favetta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
LRRK2 regulates synaptic function through BDNF signaling and actin cytoskeleton
Giulia Tombesi, Shiva N. Kompella, Giulia Favetta, et al.
(2024)
Open Access
Impaired neurogenesis and synaptogenesis in iPSC-derived Parkinson’s patient cortical neurons with D620N VPS35 mutation
Ute Scheller, ChoongKu Lee, Philip Seibler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2024)
Open Access
RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors
Dan Dou, Jayne Aiken, Erika L.F. Holzbaur
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Are LRRK2 mysteries lurking in the gut?
Adrien de Guilhem de Lataillade, Carolina Pellegrini, Michel Neunlist, et al.
AJP Gastrointestinal and Liver Physiology (2023) Vol. 325, Iss. 5, pp. G429-G435
Closed Access | Times Cited: 1
Novel Macrocyclic LRRK2 Inhibitors for Treating Parkinson’s Disease
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 1, pp. 25-26
Open Access | Times Cited: 2
1-Pyrazolyl-5,6-Disubstituted Indazole Derivatives as LRRK2 Inhibitors for Treating Parkinson’s Disease
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 3, pp. 310-311
Open Access | Times Cited: 2
Preface to the Special Issue “Presynaptic Dysfunction and Disease”
Karen J. Smillie, Michael A. Cousin, Sarah L. Gordon
Journal of Neurochemistry (2021) Vol. 157, Iss. 2, pp. 102-106
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top